Retraction statement to Advances in the physiological and pathological implications of cholesterol [Biological Reviews 88, (2013), 825-843] DOI: 10.1111/brv.12025;Advances in the physiological and pathological implications of cholesterol

Biological Reviews

Volumn 88, Issue 4, 2013, Pages 825-843

  Cortes, Victor A ^a   Busso, Dolores ^a   Mardones, Pablo ^a   Maiz, Alberto ^a   Arteaga, Antonio ^a   Nervi, Flavio ^a   Rigotti, Attilio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Alzheimer's disease; Atherosclerosis; Cholesterol; Mevalonate pathway; Nuclear receptors

Indexed keywords

ANIMALIA;

EID: 84884988945     PISSN: 14647931     EISSN: 1469185X     Source Type: Journal    
DOI: 10.1111/brv.12192     Document Type: Erratum

References (187)

1. Amaratunga, A., Abraham, C. R., Edwards, R. B., Sandell, J. H., Schreiber, B. M. & Fine, R. E. (1996). Apolipoprotein E is synthesized in the retina by Muller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells. Journal of Biological Chemistry 271, 5628-5632.
2. Andersson, H. C., Kratz, L. & Kelley, R. (2002). Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay. American Journal of Medical Genetics 113, 315-319.
3. Aoki, K., Uchihara, T., Sanjo, N., Nakamura, A., Ikeda, K., Tsuchiya, K. & Wakayama, Y. (2003). Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke 34, 875-880.
4. Apfel, R., Benbrook, D., Lernhardt, E., Ortiz, M. A., Salbert, G. & Pfahl, M. (1994). A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Molecular and Cellular Biology 14, 7025-7035.
5. Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., Piccardo, P., Ghetti, B. & Paul, S. M. (1997). Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nature Genetics 17, 263-264.
6. Baranowski, M. (2008). Biological role of liver X receptors. Journal of Physiology and Pharmacology 59(Suppl 7), 31-55.
7. Barrett, P. J., Song, Y., Van Horn, W. D., Hustedt, E. J., Schafer, J. M., Hadziselimovic, A., Beel, A. J. & Sanders, C. R. (2012). The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336, 1168-1171.
8. Beffert, U., Morfini, G., Bock, H. H., Reyna, H., Brady, S. T. & Herz, J. (2002). Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. Journal of Biological Chemistry 277, 49958-49964.
9. Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., Berk, B. C. & Zlokovic, B. V. (2012). Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512-516.
10. Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R. & Hobbs, H. H. (2000). Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290, 1771-1775.
11. Bjorkhem, I., Andersson, U., Ellis, E., Alvelius, G., Ellegard, L., Diczfalusy, U., Sjovall, J. & Einarsson, C. (2001). From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. Journal of Biological Chemistry 276, 37004-37010.
12. Bloch, K. (1965). The biological synthesis of cholesterol. Science 150, 19-28.
13. Bloch, K. E. (1979). Speculations on the evolution of sterol structure and function. CRC Critical Reviews in Biochemistry 7, 1-5.
14. Bloch, K. E. (1983). Sterol structure and membrane function. CRC Critical Reviews in Biochemistry 14, 47-92.
15. Bowman, G. L., Kaye, J. A. & Quinn, J. F. (2012). Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease. Current Gerontology and Geriatrics Research 2012, 184042.
16. Briand, F., Tréguier, M., André, A., Grillot, D., Issandou, M., Ouguerram, K. & Sulpice, T. (2010). Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model. Journal of Lipid Research 51, 763-770.
17. Brown, M. S. & Goldstein, J. L. (1980). Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. Journal of Lipid Research 21, 505-517.
18. Brown, M. S. & Goldstein, J. L. (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47.
19. Brown, M. S. & Goldstein, J. L. (1997). The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331-340.
20. Burke, K. T., Colvin, P. L., Myatt, L., Graf, G. A., Schroeder, F. & Woollett, L. A. (2009). Transport of maternal cholesterol to the fetus is affected by maternal plasma cholesterol concentrations in the golden Syrian hamster. Journal of Lipid Research 50, 1146-1155.
21. Carstea, E. D., Morris, J. A., Coleman, K. G., Loftus, S. K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M. A., Pavan, W. J., Krizman, D. B., Nagle, J., Polymeropoulos, M. H., Sturley, S. L., Ioannou, Y. A., Higgins, M. E., Comly, M., Cooney, A., Brown, A., Kaneski, C. R., Blanchette-Mackie, E. J., Dwyer, N. K., Neufeld, E. B., Chang, T. Y., Liscum, L., Tagle, D. A., et al. (1997). Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277, 228-231[see comments].
22. Chen, F., Ma, L., Dawson, P. A., Sinal, C. J., Sehayek, E., Gonzalez, F. J., Breslow, J., Ananthanarayanan, M. & Shneider, B. L. (2003). Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. Journal of Biological Chemistry 278, 19909-19916.
23. Cohen, J. C., Boerwinkle, E., Moseley, T. H. & Hobbs, H. H. (2006). Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. The New England Journal of Medicine 354, 1264-1272.
24. Coppens, I., Sinai, A. P. & Joiner, K. A. (2000). Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. The Journal of Cell Biology 149, 167-180.
25. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L. & Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
26. Cortes, V., Quezada, N., Rigotti, A. & Maiz, A. (2005). New heterodimeric nuclear receptors: key metabolic regulators with relevance in the pathophysiology and therapy of dyslipidemias and diabetes mellitus. Revista Médica de Chile 133, 1483-1492.
27. Crowder, C. M., Westover, E. J., Kumar, A. S., Ostlund, R. E. Jr. & Covey, D. F. (2001). Enantiospecificity of cholesterol function in vivo. Journal of Biological Chemistry 276, 44369-44372.
28. Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M. & Zlokovic, B. V. (2008). apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. Journal of Clinical Investigation 118, 4002-4013.
29. DeBose-Boyd, R. A. (2008). Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Research 18, 609-621.
30. DeMattos, R. B., Brendza, R. P., Heuser, J. E., Kierson, M., Cirrito, J. R., Fryer, J., Sullivan, P. M., Fagan, A. M., Han, X. & Holtzman, D. M. (2001). Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochemistry International 39, 415-425.
31. Di Paolo, G. & Kim, T. W. (2011). Linking lipids to Alzheimer's disease: cholesterol and beyond. Nature Reviews Neuroscience 12, 284-296.
32. Dietschy, J. M. & Turley, S. D. (2004). Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. Journal of Lipid Research 45, 1375-1397.
33. Dietschy, J. M., Turley, S. D. & Spady, D. K. (1993). Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. Journal of Lipid Research 34, 1637-1659.
34. Duran-Sandoval, D., Cariou, B., Percevault, F., Hennuyer, N., Grefhorst, A., van Dijk, T. H., Gonzalez, F. J., Fruchart, J. C., Kuipers, F. & Staels, B. (2005). The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. Journal of Biological Chemistry 280, 29971-29979.
35. Edison, R. J., Berg, K., Remaley, A., Kelley, R., Rotimi, C., Stevenson, R. E. & Muenke, M. (2007). Adverse birth outcome among mothers with low serum cholesterol. Pediatrics 120, 723-733.
36. Edison, R. J. & Muenke, M. (2005). Gestational exposure to lovastatin followed by cardiac malformation misclassified as holoprosencephaly. The New England Journal of Medicine 352, 2759.
37. Engelking, L. J., Evers, B. M., Richardson, J. A., Goldstein, J. L., Brown, M. S. & Liang, G. (2006). Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin. Journal of Clinical Investigation 116, 2356-2365.
38. Engelking, L. J., Kuriyama, H., Hammer, R. E., Horton, J. D., Brown, M. S., Goldstein, J. L. & Liang, G. (2004). Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. Journal of Clinical Investigation 113, 1168-1175.
39. Engelking, L. J., Liang, G., Hammer, R. E., Takaishi, K., Kuriyama, H., Evers, B. M., Li, W.-P., Horton, J. D., Goldstein, J. L. & Brown, M. S. (2005). Schoenheimer effect explained - feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. Journal of Clinical Investigation 115, 2489-2498.
40. Farese, R. V. Jr., Ruland, S. L., Flynn, L. M., Stokowski, R. P. & Young, S. G. (1995). Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proceedings of the National Academy of Sciences of the United States of America 92, 1774-1778.
41. Feng, B., Yao, P. M., Li, Y., Devlin, C. M., Zhang, D., Harding, H. P., Sweeney, M., Rong, J. X., Kuriakose, G., Fisher, E. A., Marks, A. R., Ron, D. & Tabas, I. (2003a). The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nature Cell Biology 5, 781-792.
42. Feng, B., Zhang, D., Kuriakose, G., Devlin, C. M., Kockx, M. & Tabas, I. (2003b). Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 100, 10423-10428.
43. Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., Evans, R. M. & Weinberger, C. (1995). Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81, 687-693.
44. Francis, G. A., Knopp, R. H. & Oram, J. F. (1995). Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. Journal of Clinical Investigation 96, 78-87.
45. Franz, G., Reindl, M., Patel, S. C., Beer, R., Unterrichter, I., Berger, T., Schmutzhard, E., Poewe, W. & Kampfl, A. (1999). Increased expression of apolipoprotein D following experimental traumatic brain injury. Journal of Neurochemistry 73, 1615-1625.
46. Gilk, S. D., Beare, P. A. & Heinzen, R. A. (2010). Coxiella burnetii expresses a functional Δ24 sterol reductase. Journal of Bacteriology 192, 6154-6159.
47. Goldstein, J. L. & Brown, M. S. (1974). Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. Journal of Biological Chemistry 249, 5153-5162.
48. Goldstein, J. L. & Brown, M. S. (1990). Regulation of the mevalonate pathway. Nature 343, 425-430.
49. Goldstein, J. L., DeBose-Boyd, R. A. & Brown, M. S. (2006). Protein sensors for membrane sterols. Cell 124, 35-46.
50. Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., Maloney, P. R., Willson, T. M. & Kliewer, S. A. (2000). A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Molecular Cell 6, 517-526.
51. Grober, J., Zaghini, I., Fujii, H., Jones, S. A., Kliewer, S. A., Willson, T. M., Ono, T. & Besnard, P. (1999). Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. Journal of Biological Chemistry 274, 29749-29754.
52. Haddad, I. A., Ordovas, J. M., Fitzpatrick, T. & Karathanasis, S. K. (1986). Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes. Journal of Biological Chemistry 261, 13268-13277.
53. Haines, T. H. (2001). Do sterols reduce proton and sodium leaks through lipid bilayers? Progress in Lipid Research 40, 299-324.
54. Hauser, P. S., Narayanaswami, V. & Ryan, R. O. (2011). Apolipoprotein E: from lipid transport to neurobiology. Progress in Lipid Research 50, 62-74.
55. Herz, J. (2009). Apolipoprotein E receptors in the nervous system. Current Opinion in Lipidology 20, 190-196.
56. Herz, J. & Bock, H. H. (2002). Lipoprotein receptors in the nervous system. Annual Review of Biochemistry 71, 405-434.
57. Herz, J., Chen, Y., Masiulis, I. & Zhou, L. (2009). Expanding functions of lipoprotein receptors. Journal of Lipid Research 50(Suppl), S287-S292.
58. Holtzman, D. M., Herz, J. & Bu, G. (2012). Apolipoprotein e and apolipoprotein e receptors: normal biology and roles in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2, a006312.
59. Honzumi, S., Shima, A., Hiroshima, A., Koieyama, T. & Terasaka, N. (2011). Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1811, 1136-1145.
60. van der Hoorn, J. W. A., Lindén, D., Lindahl, U., Bekkers, M. E. A., Voskuilen, M., Nilsson, R., Oscarsson, J., Lindstedt, E. L. & Princen, H. M. G. (2011). Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels. British Journal of Pharmacology 162, 1553-1563.
61. Horton, J. D., Cohen, J. C. & Hobbs, H. H. (2009). PCSK9: a convertase that coordinates LDL catabolism. Journal of Lipid Research 50(Suppl), S172-S177.
62. Horton, J. D., Goldstein, J. L. & Brown, M. S. (2002). SREBPs:activators of the complete program of cholesterol and fatty acid synthesis in the liver. Journal of Clinical Investigation 109, 1125-1131.
63. Howe, D. & Heinzen, R. A. (2006). Coxiella burnetii inhabits a cholesterol-rich vacuole and influences cellular cholesterol metabolism. Cell Microbiology 8, 496-507.
64. Huang, Y. & Mucke, L. (2012). Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222.
65. Hui, L., Chen, X. & Geiger, J. D. (2012). Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons. Life Sciences 91, 1159-1168.
66. Huster, D., Scheidt, H. A., Arnold, K., Herrmann, A. & Muller, P. (2005). Desmosterol may replace cholesterol in lipid membranes. Biophysical Journal 88, 1838-1844.
67. Ikonen, E. (2008). Cellular cholesterol trafficking and compartmentalization. Nature Review Molecular and Cellular Biology 9, 125-138.
68. Im, S.-S. & Osborne, T. F. (2011). Liver X receptors in atherosclerosis and inflammation. Circulation Research 108, 996-1001.
69. Inagaki, T., Moschetta, A., Lee, Y. K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., Mangelsdorf, D. J. & Kliewer, S. A. (2006). Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proceedings of the National Academy of Sciences of the United States of America 103, 3920-3925.
70. Jakobsson, T., Treuter, E., Gustafsson, J. A. & Steffensen, K. R. (2012). Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends in Pharmacological Sciences 33, 394-404.
71. Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R. & Mangelsdorf, D. J. (1996). An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383, 728-731.
72. Jiang, Q., Lee, C. Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., Richardson, J. C., Smith, J. D., Comery, T. A., Riddell, D., Holtzman, D. M., Tontonoz, P. & Landreth, G. E. (2008). ApoE promotes the proteolytic degradation of Abeta. Neuron 58, 681-693.
73. Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J. & Tontonoz, P. (2003). Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nature Medicine 9, 213-219.
74. Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G., Goodman, J., Hagger, G. N., Tran, J., Tippin, T. K., Wang, X., Lusis, A. J., Hsueh, W. A., Law, R. E., Collins, J. L., Willson, T. M. & Tontonoz, P. (2002). Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proceedings of the National Academy of Sciences of the United States of America 99, 7604-7609.
75. Kellner-Weibel, G., Jerome, W. G., Small, D. M., Warner, G. J., Stoltenborg, J. K., Kearney, M. A., Corjay, M. H., Phillips, M. C. & Rothblat, G. H. (1998). Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death. Arteriosclerosis, Thrombosis, and Vascular Biology 18, 423-431.
76. Kim, W. S., Weickert, C. S. & Garner, B. (2008). Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. Journal of Neurochemistry 104, 1145-1166.
77. Klein, A., Amigo, L., Retamal, M. J., Morales, M. G., Miquel, J. F., Rigotti, A. & Zanlungo, S. (2006). NPC2 is expressed in human and murine liver and secreted into bile: potential implications for body cholesterol homeostasis. Hepatology 43, 126-133.
78. Koldamova, R. P., Lefterov, I. M., Ikonomovic, M. D., Skoko, J., Lefterov, P. I., Isanski, B. A., DeKosky, S. T. & Lazo, J. S. (2003). 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. Journal of Biological Chemistry 278, 13244-13256.
79. Kotti, T., Head, D. D., McKenna, C. E. & Russell, D. W. (2008). Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation. Proceedings of the National Academy of Sciences of the United States of America 105, 11394-11399.
80. Kotti, T. J., Ramirez, D. M. O., Pfeiffer, B. E., Huber, K. M. & Russell, D. W. (2006). Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proceedings of the National Academy of Sciences of the United States of America 103, 3869-3874.
81. Kurzchalia, T. V. & Ward, S. (2003). Why do worms need cholesterol? Nature Cell Biology 5, 684-688.
82. Kwon, H. J., Abi-Mosleh, L., Wang, M. L., Deisenhofer, J., Goldstein, J. L., Brown, M. S. & Infante, R. E. (2009). Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 137, 1213-1224.
83. LaDu, M. J., Gilligan, S. M., Lukens, J. R., Cabana, V. G., Reardon, C. A., Van Eldik, L. J. & Holtzman, D. M. (1998). Nascent astrocyte particles differ from lipoproteins in CSF. Journal of Neurochemistry 70, 2070-2081.
84. Laffitte, B. A., Repa, J. J., Joseph, S. B., Wilpitz, D. C., Kast, H. R., Mangelsdorf, D. J. & Tontonoz, P. (2001). LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proceedings of the National Academy of Sciences of the United States of America 98, 507-512.
85. Lange, Y. & Ramos, B. V. (1983). Analysis of the distribution of cholesterol in the intact cell. Journal of Biological Chemistry 258, 15130-15134.
86. Lange, Y., Ye, J., Rigney, M. & Steck, T. L. (1999). Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. Journal of Lipid Research 40, 2264-2270.
87. Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J. L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A. & Willson, T. M. (1997). Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. Journal of Biological Chemistry 272, 3137-3140.
88. Leiva, A., Verdejo, H., Benitez, M. L., Martinez, A., Busso, D. & Rigotti, A. (2011). Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism. Atherosclerosis 217, 299-307.
89. Li, Y., Ge, M., Ciani, L., Kuriakose, G., Westover, E. J., Dura, M., Covey, D. F., Freed, J. H., Maxfield, F. R., Lytton, J. & Tabas, I. (2004). Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. Journal of Biological Chemistry 279, 37030-37039.
90. Linck, L. M., Hayflick, S. J., Lin, D. S., Battaile, K. P., Ginat, S., Burlingame, T., Gibson, K. M., Honda, M., Honda, A., Salen, G., Tint, G. S., Connor, W. E. & Steiner, R. D. (2000). Fetal demise with Smith-Lemli-Opitz syndrome confirmed by tissue sterol analysis and the absence of measurable 7-dehydrocholesterol Delta(7)-reductase activity in chorionic villi. Prenatal Diagnosis 20, 238-240.
91. Lindegaard, M. L., Wassif, C. A., Vaisman, B., Amar, M., Wasmuth, E. V., Shamburek, R., Nielsen, L. B., Remaley, A. T. & Porter, F. D. (2008). Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome. Human Molecular Genetics 17, 3806-3813.
92. Liscum, L. & Munn, N. J. (1999). Intracellular cholesterol transport. Biochimica et Biophysica Acta 1438, 19-37.
93. Lund, E. G., Guileyardo, J. M. & Russell, D. W. (1999). cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proceedings of the National Academy of Sciences of the United States of America 96, 7238-7243.
94. Lund, E. G., Xie, C., Kotti, T., Turley, S. D., Dietschy, J. M. & Russell, D. W. (2003). Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. Journal of Biological Chemistry 278, 22980-22988.
95. Lusis, A. J. (2000). Atherosclerosis. Nature 407, 233-241.
96. Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J. & Shan, B. (1999). Identification of a nuclear receptor for bile acids. Science 284, 1362-1365[see comments].
97. Matyash, V., Geier, C., Henske, A., Mukherjee, S., Hirsh, D., Thiele, C., Grant, B., Maxfield, F. R. & Kurzchalia, T. V. (2001). Distribution and transport of cholesterol in Caenorhabditis elegans. Molecular Biology of the Cell 12, 1725-1736.
98. Mauch, D. H., Nagler, K., Schumacher, S., Goritz, C., Muller, E. C., Otto, A. & Pfrieger, F. W. (2001). CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357.
99. McConihay, J. A., Honkomp, A. M., Granholm, N. A. & Woollett, L. A. (2000). Maternal high density lipoproteins affect fetal mass and extra-embryonic fetal tissue sterol metabolism in the mouse. Journal of Lipid Research 41, 424-432.
100. McKenney, J. M., Koren, M. J., Kereiakes, D. J., Hanotin, C., Ferrand, A. C. & Stein, E. A. (2012). Safety and efficacy of a monoclonal antibody to proprotein convertase Subtilisin/Kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy. Journal of the American College of Cardiology 59, 2344-2353.
101. van Meer, G., Voelker, D. R. & Feigenson, G. W. (2008). Membrane lipids: where they are and how they behave. Nature Reviews. Molecular and Cellular Biology 9, 112-124.
102. Merris, M., Wadsworth, W. G., Khamrai, U., Bittman, R., Chitwood, D. J. & Lenard, J. (2003). Sterol effects and sites of sterol accumulation in Caenorhabditis elegans: developmental requirement for 4alpha-methyl sterols. Journal of Lipid Research 44, 172-181.
103. Miao, B., Zondlo, S., Gibbs, S., Cromley, D., Hosagrahara, V. P., Kirchgessner, T. G., Billheimer, J. & Mukherjee, R. (2004). Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. Journal of Lipid Research 45, 1410-1417.
104. Mishkel, M. A. (1974). Neonatal plasma lipids as measured in cord blood. Canadian Medical Association Journal 111, 775-780.
105. Mockel, B., Zinke, H., Flach, R., Weiss, B., Weiler-Guttler, H. & Gassen, H. G. (1994). Expression of apolipoprotein A-I in porcine brain endothelium in vitro. Journal of Neurochemistry 62, 788-798.
106. Modell, W. (1967). Mass drug catastrophes and the roles of science and technology. Science 156, 346-351.
107. Muldoon, M. F., Barger, S. D., Ryan, C. M., Flory, J. D., Lehoczky, J. P., Matthews, K. A. & Manuck, S. B. (2000). Effects of lovastatin on cognitive function and psychological well-being. American Journal of Medicine 108, 538-546.
108. Muldoon, M. F., Ryan, C. M., Sereika, S. M., Flory, J. D. & Manuck, S. B. (2004). Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. American Journal of Medicine 117, 823-829.
109. Naik, S. U., Wang, X., Da Silva, J. S., Jaye, M., Macphee, C. H., Reilly, M. P., Billheimer, J. T., Rothblat, G. H. & Rader, D. J. (2006). Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113, 90-97.
110. Nieweg, K., Schaller, H. & Pfrieger, F. W. (2009). Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. Journal of Neurochemistry 109, 125-134.
111. Nissen, S. E., Tuzcu, E. M., Brewer, H. B., Sipahi, I., Nicholls, S. J., Ganz, P., Schoenhagen, P., Waters, D. D., Pepine, C. J., Crowe, T. D., Davidson, M. H., Deanfield, J. E., Wisniewski, L. M., Hanyok, J. J. & Kassalow, L. M. (2006). Effect of ACAT inhibition on the progression of coronary atherosclerosis. The New England Journal of Medicine 354, 1253-1263.
112. Nwokoro, N. A., Wassif, C. A. & Porter, F. D. (2001). Genetic disorders of cholesterol biosynthesis in mice and humans. Molecular Genetics and Metabolism 74, 105-119.
113. Olson, R. E. (1998). Discovery of the lipoproteins, their role in fat transport and their significance as risk factors. Journal of Nutrition 128, 439S-443S.
114. Ong, W. Y., He, Y., Suresh, S. & Patel, S. C. (1997). Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus. Neuroscience 79, 359-367.
115. Ory, D. S. (2004). Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home? Circulation Research 95, 660-670.
116. Palinski, W., Yamashita, T., Freigang, S. & Napoli, C. (2007). Developmental programming: maternal hypercholesterolemia and immunity influence susceptibility to atherosclerosis. Nutrition Reviews 65, S182-S187.
117. Pandey, A. K. & Sassetti, C. M. (2008). Mycobacterial persistence requires the utilization of host cholesterol. Proceedings of the National Academy of Sciences of the United States of America 105, 4376-4380.
118. Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D. & Lehmann, J. M. (1999). Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365-1368.
119. Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J. M., Hammer, R. E. & Mangelsdorf, D. J. (1998). Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93, 693-704.
120. Pfenninger, K. H. (2009). Plasma membrane expansion: a neuron's Herculean task. Nature Reviews Neuroscience 10, 251-261.
121. Pfrieger, F. W. (2003). Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? Bioessays 25, 72-78.
122. Pfrieger, F. W. & Ungerer, N. (2011). Cholesterol metabolism in neurons and astrocytes. Progress in Lipid Research 50, 357-371.
123. Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D. & Weisgraber, K. H. (1987). Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. Journal of Biological Chemistry 262, 14352-14360.
124. Plass, J. R., Mol, O., Heegsma, J., Geuken, M., Faber, K. N., Jansen, P. L. & Muller, M. (2002). Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35, 589-596.
125. Porter, F. D. (2003). Human malformation syndromes due to inborn errors of cholesterol synthesis. Current Opinion in Pediatrics 15, 607-613.
126. Quan, G., Xie, C., Dietschy, J. M. & Turley, S. D. (2003). Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Research Developmental Brain Research 146, 87-98.
127. Radhakrishnan, A., Goldstein, J. L., McDonald, J. G. & Brown, M. S. (2008). Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metabolism 8, 512-521.
128. Rassart, E., Bedirian, A., Do Carmo, S., Guinard, O., Sirois, J., Terrisse, L. & Milne, R. (2000). Apolipoprotein D. Biochimica et Biophysica Acta 1482, 185-198.
129. Repa, J. J., Berge, K. E., Pomajzl, C., Richardson, J. A., Hobbs, H. & Mangelsdorf, D. J. (2002). Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. Journal of Biological Chemistry 277, 18793-18800.
130. Repa, J. J., Li, H., Frank-Cannon, T. C., Valasek, M. A., Turley, S. D., Tansey, M. G. & Dietschy, J. M. (2007). Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 27, 14470-14480.
131. Rigotti, A., Miettinen, H. E. & Krieger, M. (2003). The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocrine Reviews 24, 357-387.
132. Rodriguez-Acebes, S., de la Cueva, P., Fernandez-Hernando, C., Ferruelo, A. J., Lasuncion, M. A., Rawson, R. B., Martinez-Botas, J. & Gomez-Coronado, D. (2009). Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line. Biochemical Journal 420, 305-315.
133. Roheim, P. S., Carey, M., Forte, T. & Vega, G. L. (1979). Apolipoproteins in human cerebrospinal fluid. Proceedings of the National Academy of Sciences of the United States of America 76, 4646-4649.
134. Ross, R. (1999). Atherosclerosis--an inflammatory disease. The New England Journal of Medicine 340, 115-126.
135. Rossant, J. & Cross, J. C. (2001). Placental development: lessons from mouse mutants. Nature Reviews Genetics 2, 538-548.
136. Roux, C. & Aubry, M. (1966). Teratogenic action in the rat of an inhibitor of cholesterol synthesis, AY 9944. Comptes Rendus des Séances de la Société de Biologie et de ses Filiales 160, 1353-1357.
137. Russell, D. W., Halford, R. W., Ramirez, D. M., Shah, R. & Kotti, T. (2009). Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annual Review of Biochemistry 78, 1017-1040.
138. Sadowski, M. J., Pankiewicz, J., Scholtzova, H., Mehta, P. D., Prelli, F., Quartermain, D. & Wisniewski, T. (2006). Blocking the apolipoprotein E/amyloid-β interaction as a potential therapeutic approach for Alzheimer's disease. Proceedings of the National Academy of Sciences 103, 18787-18792.
139. Saher, G., Rudolphi, F., Corthals, K., Ruhwedel, T., Schmidt, K.-F., Lowel, S., Dibaj, P., Barrette, B., Mobius, W. & Nave, K.-A. (2012). Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nature Medicine 18, 1130-1135.
140. Sanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B. & Roses, A. D. (1994). Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. Journal of Clinical Investigation 94, 860-869.
141. Santander, N. G., Contreras-Duarte, S., Awad, M. F., Lizama, C., Passalacqua, I., Rigotti, A. & Busso, D. (2012). Developmental abnormalities in mouse embryos lacking the HDL receptor SR-BI. Human Molecular Genetics (doi: 10.1093/hmg/dds510), in press.
142. Schipper, H. M. (2011). Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment. Neurobiology of Aging 32, 778-790.
143. Schmid, K. E. & Woollett, L. A. (2003). Differential effects of polyunsaturated fatty acids on sterol synthesis rates in adult and fetal tissues of the hamster: consequence of altered sterol balance. American Journal of Physiology. Gastrointestinal and Liver Physiology 285, G796-G803.
144. Schulman, I. G. (2010). Nuclear receptors as drug targets for metabolic disease. Advanced Drug Delivery Reviews 62, 1307-1315.
145. Simons, K. & Ehehalt, R. (2002). Cholesterol, lipid rafts, and disease. Journal of Clinical Investigation 110, 597-603.
146. Simons, K. & Toomre, D. (2000). Lipid rafts and signal transduction. Nature Reviews Molecular Cell Biology 1, 31-39.
147. Simons, M. & Trotter, J. (2007). Wrapping it up: the cell biology of myelination. Current Opinion in Neurobiology 17, 533-540.
148. Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., Lloyd-Jones, D. M., Minissian, M., Mosca, L., Peterson, E. D., Sacco, R. L., Spertus, J., Stein, J. H. & Taubert, K. A. (2011). AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 Update. Circulation 124, 2458-2473.
149. Song, C. S., Echchgadda, I., Baek, B. S., Ahn, S. C., Oh, T., Roy, A. K. & Chatterjee, B. (2001). Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. Journal of Biological Chemistry 276, 42549-42556.
150. Stefulj, J., Panzenboeck, U., Becker, T., Hirschmugl, B., Schweinzer, C., Lang, I., Marsche, G., Sadjak, A., Lang, U., Desoye, G. & Wadsack, C. (2009). Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circulation Research 104, 600-608.
151. Stein, E. A., Mellis, S., Yancopoulos, G. D., Stahl, N., Logan, D., Smith, W. B., Lisbon, E., Gutierrez, M., Webb, C., Wu, R., Du, Y., Kranz, T., Gasparino, E. & Swergold, G. D. (2012). Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. The New England Journal of Medicine 366, 1108-1118.
152. Steinberg, D. (2004). Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I. Journal of Lipid Research 45, 1583-1593.
153. Steinberg, D., Avigan, J. & Feigelson, E. B. (1961). Effects of triparanol (Mer-29) on cholesterol biosynthesis and on blood sterol levels in man. Journal of Clinical Investigation 40, 884-893.
154. Steinhauer, J. & Treisman, J. E. (2009). Lipid-modified morphogens: functions of fats. Current Opinion in Genetics and Development 19, 308-314.
155. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. & Roses, A. D. (1993). Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 90, 8098-8102.
156. Su, Y. R., Dove, D. E., Major, A. S., Hasty, A. H., Boone, B., Linton, M. F. & Fazio, S. (2005). Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1. Circulation 111, 2373-2381.
157. Svoboda, J. A. (1999). Variability of metabolism and function of sterols in insects. CRC Critical Reviews in Biochemistry and Molecular Biology 34, 49-57.
158. Tabas, I. (2002). Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. Journal of Clinical Investigation 110, 905-911.
159. Tabas, I. (2004). Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death and Differentiation 11(Suppl 1), S12-S16.
160. Tabas, I. (2010). The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circulation Research 107, 839-850.
161. Tangirala, R. K., Bischoff, E. D., Joseph, S. B., Wagner, B. L., Walczak, R., Laffitte, B. A., Daige, C. L., Thomas, D., Heyman, R. A., Mangelsdorf, D. J., Wang, X., Lusis, A. J., Tontonoz, P. & Schulman, I. G. (2002). Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 99, 11896-11901.
162. Tardif, J. C., Gregoire, J., L'Allier, P. L., Anderson, T. J., Bertrand, O., Reeves, F., Title, L. M., Alfonso, F., Schampaert, E., Hassan, A., McLain, R., Pressler, M. L., Ibrahim, R., Lesperance, J., Blue, J., Heinonen, T. & Rodes-Cabau, J. (2004). Effects of the acyl coenzyme A: cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110, 3372-3377.
163. Tarr, P. T. & Edwards, P. A. (2008). ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2. Journal of Lipid Research 49, 169-182.
164. Tint, G. S., Yu, H., Shang, Q., Xu, G. & Patel, S. B. (2006). The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. Journal of Lipid Research 47, 1535-1541.
165. Turley, S. D., Burns, D. K., Rosenfeld, C. R. & Dietschy, J. M. (1996). Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep. Journal of Lipid Research 37, 1953-1961.
166. Turley, S. D., Spady, D. K. & Dietschy, J. M. (1995). Role of liver in the synthesis of cholesterol and the clearance of low density lipoproteins in the cynomolgus monkey. Journal of Lipid Research 36, 67-79.
167. Vance, J. E. & Hayashi, H. (2010). Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochimica et Biophysica Acta 1801, 806-818.
168. Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A. & Tontonoz, P. (2000a). Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proceedings of the National Academy of Sciences of the United States of America 97, 12097-12102.
169. Venkateswaran, A., Repa, J. J., Lobaccaro, J. M., Bronson, A., Mangelsdorf, D. J. & Edwards, P. A. (2000b). Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. Journal of Biological Chemistry 275, 14700-14707.
170. Vetrivel, K. S. & Thinakaran, G. (2010). Membrane rafts in Alzheimer's disease beta-amyloid production. Biochimica et Biophysica Acta 1801, 860-867.
171. Waelsch, H., Sperry, W. M. & Stoyanoff, V. A. (1940). Lipid metabolism in brain during myelination. Journal of Biological Chemistry 135, 297-302.
172. Wang, N., Lan, D., Chen, W., Matsuura, F. & Tall, A. R. (2004). ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proceedings of the National Academy of Sciences of the United States of America 101, 9774-9779.
173. Wang, M. L., Motamed, M., Infante, R. E., Abi-Mosleh, L., Kwon, H. J., Brown, M. S. & Goldstein, J. L. (2010). Identification of surface residues on Niemann-Pick C2 essential for hydrophobic handoff of cholesterol to NPC1 in lysosomes. Cell Metabolism 12, 166-173.
174. Waterham, H. R. (2006). Defects of cholesterol biosynthesis. FEBS Letters 580, 5442-5449.
175. Waterham, H. R., Koster, J., Romeijn, G. J., Hennekam, R. C., Vreken, P., Andersson, H. C., FitzPatrick, D. R., Kelley, R. I. & Wanders, R. J. (2001). Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. American Journal of Human Genetics 69, 685-694.
176. Wechsler, A., Brafman, A., Shafir, M., Heverin, M., Gottlieb, H., Damari, G., Gozlan-Kelner, S., Spivak, I., Moshkin, O., Fridman, E., Becker, Y., Skaliter, R., Einat, P., Faerman, A., Bjorkhem, I. & Feinstein, E. (2003). Generation of viable cholesterol-free mice. Science 302, 2087.
177. Willnow, T. E., Hammes, A. & Eaton, S. (2007). Lipoproteins and their receptors in embryonic development: more than cholesterol clearance. Development 134, 3239-3249.
178. Willnow, T. E., Hilpert, J., Armstrong, S. A., Rohlmann, A., Hammer, R. E., Burns, D. K. & Herz, J. (1996). Defective forebrain development in mice lacking gp330/megalin. Proceedings of the National Academy of Sciences of the United States of America 93, 8460-8464.
179. Wolman, M. (1995). Wolman disease and its treatment. Clinical Pediatrics 34, 207-212.
180. Woollett, L. A. (2011). Review: transport of maternal cholesterol to the fetal circulation. Placenta 32(Suppl 2), S218-S221.
181. Xu, Q., Bernardo, A., Walker, D., Kanegawa, T., Mahley, R. W. & Huang, Y. (2006). Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 26, 4985-4994.
182. Yanagisawa, K. & Matsuzaki, K. (2002). Cholesterol-dependent aggregation of amyloid beta-protein. Annals of the New York Academy of Sciences 977, 384-386.
183. Yao, L., Jenkins, K., Horn, P. S., Lichtenberg, M. H. & Woollett, L. A. (2007). Inability to fully suppress sterol synthesis rates with exogenous sterol in embryonic and extraembyronic fetal tissues. Biochimica et Biophysica Acta 1771, 1372-1379.
184. Yi, P., Han, Z., Li, X. & Olson, E. N. (2006). The mevalonate pathway controls heart formation in Drosophila by isoprenylation of Ggamma1. Science 313, 1301-1303.
185. Yoshida, S. & Wada, Y. (2005). Transfer of maternal cholesterol to embryo and fetus in pregnant mice. Journal of Lipid Research 46, 2168-2174.
186. Yu, L., Hammer, R. E., Li-Hawkins, J., von Bergmann, K., Lutjohann, D., Cohen, J. C. & Hobbs, H. H. (2002). Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proceedings of the National Academy of Sciences of the United States of America 99, 16237-16242.
187. Zhang, H., Ma, Q., Zhang, Y. W. & Xu, H. (2012). Proteolytic processing of Alzheimer's beta-amyloid precursor protein. Journal of Neurochemistry 120(Suppl 1), 9-21.